Advertisement
Advertisement

CERS

CERS logo

Cerus Corp

2.64
USD
Sponsored
+0.05
+1.93%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

2.68

+0.04
+1.48%

Cerus Corp Profile

About

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.

Info & Links

CEO

William M. Greenman

Headquarters

1220 CONCORD AVENUE, SUITE 600
CONCORD, CA 94520, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.cerus.com

Auditor

Ernst & Young LLP

Share holders

113

Employees

275

Cerus Corp Statistics

Valuation Measures

Market Capitalization2

536.79M

Enterprise Value

593.77M

Enterprise Value/EBITDA(ttm)

-367.43

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.78

Price to Book(mrq)

5.65

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

60.09%

Operating Margin(ttm)

-7.58%

Profit Margin(ttm)

-7.18%

Return on Equity(ttm)

-26.09%

Return on Invested Capital(ttm)

-13.52%

Return on Assets(ttm)

-7.29%

Income Statement

Revenue(ttm)

244.84M

Revenue Per Share(ttm)

1.22

Gross Profit(ttm)

143.04M

EBITDA(ttm)3

-1.62M

Net Income Available to Common(ttm)

-9.55M

Diluted EPS(ttm)

-0.08

Share Statistics

Beta (5Y Monthly)

1.63

52-Week Change

92.70%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

200.37M

Dividend Yield

0.00%

Float4

181.41M

% Held by Insiders

5.60%

% Held by Institutions

78.37%

Balance Sheet

Total Cash(mrq)

80.42M

Total Cash Per Share(mrq)

0.40

Total Debt(mrq)

84.83M

Total Debt/Equity(mrq)

129.13%

Current Ratio(mrq)

1.73%

Quick Ratio(mrq)

1.17%

Book Value Per Share(mrq)

0.34

Cash Flow

Operating Cash Flow Per Share(ytd)

0.03

Free Cash Flow(ytd)

1.11M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement